Emcure Pharma Closes Trading Window for Insider Trading

Emcure Pharmaceuticals Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut effective October 01, 2026, and will reopen 48 hours after the declaration of the company's unaudited financial results for the quarter and half-year ending September 30, 2026. The specific date for the board meeting to approve these results will be communicated later. The company has also uploaded this intimation on its website.